Login

Brian Cox, CEO of SurgePays, Inc., discusses current $SURG developments at the technology and telecommunications company. 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unveiling Real Estate Insights: Rutger Arnhult Shares Journey, Market Trends, and Strategic Decisions in the Industry | Rutger Arnhult, CEO, klövern AB
00:10:00
Business Growth Plans: Diversifying Product Lines and Strengthening Technology Integration|Dhiraj Patel,Managing Director,Vikram Thermo (India) Ltd.
00:10:00
MSCI is a leading provider of critical decision support tools|Henry A. Fernandez,Chairman,Real Capital Analytics
00:10:00
"November 2022 Investment Committee Update with John Shanley, CFP®, and Dan Ballou, CFP® | Connecticut Wealth Management"
00:10:00
Backs bold entrepreneurs building the future through technology|Anish Acharya,General Partner,Andreessen Horowitz
00:10:00
Involvement inventing the breast cancer drug Herceptin and discussed the investment offering for his latest therapeutic development company|H. Michael Shepard , CEO OF ENOSI THERAPEUTICS
00:10:00
Helps company in a large number of startups|Garry Tan,Partner,Y Combinator
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.
00:10:00
Far Resources: Canadian Lithium Projects Overview
00:10:00
Nuveen is a global investment leader, managing an array of public and private assets for clients around the world and on behalf of our parent company TIAA , one of the world’s largest institutional investors,1 a highly-rated2 insurance company and a retir
00:10:00
Understanding RMDs and QCDs: Essential Pre-Tax Account Distributions | C.J. Klaas, President, Klaas Financial.
00:10:00
Gene Sheridan, CEO of Navitas Semiconductor, discusses the company's earnings beat, revenue growth expectations, and advancements in artificial intelligence.|Gene Sheridan, CEO of Navitas Semiconductor

© 2017 - Neuhu+